Image Description (Logo1)
Sildenafil Citrate Tablet, Film Coated
Product Images NDC 71335-3111
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 71335-3111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical-structure (Chemical Structure)
Figure-1 (Figure 1)
This text provides information on systolic blood pressure measurements taken at different time points in a study involving Sildenafil 100mg and Placebo. The values of blood pressure seem to be recorded pre-dose and at 15, 20, and 25 minutes post-dose.*
Figure-2 (Figure 2)
Figure-3 (Figure 3)
The text shows the change in systolic blood pressure (SBP) in mmHg for two different treatments over a period of time post-dose. The first treatment is Doxazosin with a placebo, and the second treatment is Doxazosin with Sildenafil 50 mg. The values for SBP changes are given at specific time points post-dose. Time points range from 1 to 8 hours.*
Figure-4 (Figure 4)
Figure-5 (Figure 5)
This text provides information on plasma concentrations (in ng/mL) over time (in hours) post-dose for a specific treatment involving a commercial tablet. The plasma concentrations are listed at various time intervals.*
Figure-6-1 (Figure 6 1)
This is a data set showing the % of patients at different endpoints. The data includes percentages of patients at various values ranging from 80% to 1%. The data starts at the baseline score and progresses through different endpoints.*
Figure-6-2 (Figure 6 2)
Figure-7 (Figure 7)
This text provides data on the percentage of patients reporting improvement with different dosages of sildenafil citrate in comparison to a placebo. The percentages are as follows: 100%, 82%, 74%, 63%, and 24%. The dosages tested were 25mg, 50mg, and 100mg, with varying numbers of patients in each group.*
Label (Lbl713353111)
This is information about Sildenafil tablets, each film-coated tablet contains 50mg of Sildenafil Citrate. It provides instructions to keep the tablets out of children's reach, store between 20-25°C, and dispense in a tight, light-resistant container. The tablets are manufactured by Torrent Pharmaceuticals Ltd and repackaged by Bryant Ranch Prepack, Inc. Dosage information can be found in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
